Back
Neurocrine Biosciences Vs. Repligen Industry Stock Comparison
Sell
41
NBIX
Neurocrine Biosciences
Last Price:
118.32
Seasonality Move:
9.9%
Buy
61
RGEN
Repligen
Last Price:
143.23
Seasonality Move:
-3.11%
Sell
41
Neurocrine Biosciences (NBIX)
is a Sell
Is Neurocrine Biosciences a Buy, Sell or Hold?
- The current Neurocrine Biosciences [NBIX] share price is $120.46. The Score for NBIX is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
- NBIX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
61
Repligen (RGEN)
is a Buy
Is Repligen a Buy, Sell or Hold?
- The current Repligen [RGEN] share price is $145.78. The Score for RGEN is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
- RGEN is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
NBIX Stock Price Chart
What is Neurocrine Biosciences's stock price today?
-
The Neurocrine Biosciences share price today is $120.46
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NBIX is experiencing slight selling pressure.
NBIX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -6.08 | Sell |
Relative Strength Index (14 RSI): | 32.31 | Sell |
Chaikin Money Flow: | -385962 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (118.79 - 145.97) | Sell |
Bollinger Bands (100): | (129.79 - 147.61) | Sell |
RGEN Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -2.09 | Sell |
Relative Strength Index (14 RSI): | 50.4 | Buy |
Chaikin Money Flow: | -350028 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (141.22 - 151.68) | Sell |
Bollinger Bands (100): | (130.16 - 162.76) | Sell |
NBIX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 121.13 | Sell |
20-day SMA: | 128.4 | Sell |
50-day SMA: | 139.44 | Sell |
200-day SMA: | 136.34 | Sell |
8-day EMA: | 121.75 | Sell |
20-day EMA: | 127.22 | Sell |
50-day EMA: | 134.41 | Sell |
200-day EMA: | 133.06 | Sell |
RGEN Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 142.04 | Buy |
20-day SMA: | 144.7 | Buy |
50-day SMA: | 146.49 | Sell |
200-day SMA: | 164.76 | Sell |
8-day EMA: | 142.55 | Buy |
20-day EMA: | 144.83 | Buy |
50-day EMA: | 146.19 | Sell |
200-day EMA: | 156.5 | Sell |
Neurocrine Biosciences Earnings Growth & NBIX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.48 per share, an increase next quarter of $0.36 per share, an increase this year of $2.34 per share, and an increase next year of $1.55 per share.
Repligen Earnings Growth & RGEN Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.17 per share, an increase next quarter of $0.13 per share, a decrease this year of $0.27 per share, and an increase next year of $0.44 per share.
Neurocrine Biosciences Technical Analysis
Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Repligen Technical Analysis
Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |